Clinical Trial Update: Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck [Phase 2]

View source ↗

Summary

A Phase 2 trial of Iressa (gefitinib) with radiotherapy for locally advanced inoperable head and neck squamous cell carcinoma was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: AstraZeneca | Conditions: Head and Neck Cancer, Carcinoma, Squamous Cell | Phase 2 | Status: WITHDRAWN